ALPHARETTA, GA, Aug. 11, 2020 /CNW/ -- FDA has cleared MagVenture TMS Therapy ® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks the second indication in the US for the Danish ...
TMS has been FDA cleared for treatment-resistant major depressive disorder since 2008. Since then, over 1,000 psychiatric clinics have emerged in the US. Most private health insurance companies also ...
ALPHARETTA, Ga., May 1, 2024 /PRNewswire/ -- MagVenture is proud to announce its partnership with Magnus Medical, providing its industry-leading MagPro ® magnetic stimulation system to support an ...
COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD). In addition, ...
ALPHARETTA, GA, UNITED STATES, December 4, 2023 /EINPresswire.com/ -- MagVenture, a renowned global manufacturer of Magnetic Stimulation devices, celebrates a new ...
For people suffering from severe depression, the road to remission just became a lot shorter:The treatment is known as Transcranial Magnetic Stimulation (TMS), and MagVenture has now, as the only TMS ...
ALPHARETTA, GA, Aug. 11, 2020 /CNW/ -- FDA has cleared MagVenture TMS Therapy ® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks the second indication in the US for the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results